Código QR (código de barras bidimensional)

Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison

Abstract Introduction Matching-adjusted indirect comparisons (MAIC) were used to assess the relative efficacy of bimekizumab 160 mg every 4 weeks (Q4W) compared to guselkumab 100 mg Q4W or every 8 weeks (Q8W) at 48/52 weeks in patients with psoriatic arthritis (PsA) who were biologic disease-modifyi...

Fuld beskrivelse

Na minha lista:
Principais autores: Richard B. Warren, Iain B. McInnes, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, Philip J. Mease
Format: Artigo
Sprog:Inglês
Udgivet: Adis, Springer Healthcare 2024-03-01
Serier:Rheumatology and Therapy
Fag:
ACR
Bimekizumab
Biologics
Guselkumab
IL-17
IL-23
Online adgang:https://doi.org/10.1007/s40744-024-00659-0
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker